LUNG CIK: 1127537

Pulmonx Corp

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
208
FY22:
169
FY23:
150
FY24:
136
FY25:
102
(positive)
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
24.7
FY23:
27.4
FY24:
26.6
FY25:
27.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
194
FY23:
178
FY24:
163
FY25:
129

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
17.6
FY22:
18.5
FY23:
23.2
FY24:
24.4
FY25:
20.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
24.4
FY22:
21.2
FY23:
36.3
FY24:
52.6
FY25:
55.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
193
FY22:
154
FY23:
118
FY24:
85.8
FY25:
54.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
235
FY22:
194
FY23:
178
FY24:
163
FY25:
129

All amounts in millions USD Data source:SEC EDGAR